Literature DB >> 11805528

Autonomic dysfunction in the ICU patient.

H B Schmidt1, K Werdan, U Müller-Werdan.   

Abstract

The sympathetic-parasympathetic balance may be altered in critically ill patients. Assessment of autonomic function provides information concerning prognosis, pathogenesis, and treatment strategies in ICU-relevant disorders. Proven tools are heart rate variability, baroreflex sensitivity, and, with limitations, cardiac chemoreflex sensitivity. New nonlinear methods are being evaluated that may predict risk more precisely in critically ill patients. This article summarizes application of these tools in the ICU. In addition, a model is introduced for investigating the impaired autonomic function in multiple organ dysfunction syndrome and sepsis, integrating extrinsic mechanisms and factors that are intrinsic to the cardiac tissue. By this combined approach, the authors hope to gain insight into the pathogenesis of multiple organ dysfunction syndrome. New pathophysiologic concepts are needed for the development of treatment strategies for this life-threatening disease.

Entities:  

Mesh:

Year:  2001        PMID: 11805528     DOI: 10.1097/00075198-200110000-00002

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  38 in total

1.  [Autonomic dysfunction in cardiopulmonary diseases].

Authors:  B E Strauer; K Werdan; P von Wichert
Journal:  Internist (Berl)       Date:  2002-09       Impact factor: 0.743

2.  Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.

Authors:  Sebastian Nuding; Henning Ebelt; Robert S Hoke; Annette Krummenerl; Andreas Wienke; Ursula Müller-Werdan; Karl Werdan
Journal:  Clin Res Cardiol       Date:  2011-06-03       Impact factor: 5.460

Review 3.  [End-organ damage in inflammation and sepsis].

Authors:  U Müller-Werdan; K Werdan
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

4.  On heart rate variability and autonomic activity in homeostasis and in systemic inflammation.

Authors:  Jeremy D Scheff; Benjamin Griffel; Siobhan A Corbett; Steve E Calvano; Ioannis P Androulakis
Journal:  Math Biosci       Date:  2014-03-26       Impact factor: 2.144

Review 5.  Physiology and immunology of the cholinergic antiinflammatory pathway.

Authors:  Kevin J Tracey
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

6.  Proximal gastric motility in critically ill patients with type 2 diabetes mellitus.

Authors:  Nam Q Nguyen; Robert J Fraser; Laura K Bryant; Marianne Chapman; Richard H Holloway
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

7.  Patient-Specific Classification of ICU Sedation Levels From Heart Rate Variability.

Authors:  Sunil B Nagaraj; Siddharth Biswal; Emily J Boyle; David W Zhou; Lauren M McClain; Ednan K Bajwa; Sadeq A Quraishi; Oluwaseun Akeju; Riccardo Barbieri; Patrick L Purdon; M Brandon Westover
Journal:  Crit Care Med       Date:  2017-07       Impact factor: 7.598

8.  Prolonged elevated heart rate is a risk factor for adverse cardiac events and poor outcome after subarachnoid hemorrhage.

Authors:  J Michael Schmidt; Michael Crimmins; Hector Lantigua; Andres Fernandez; Chris Zammit; Cristina Falo; Sachin Agarwal; Jan Claassen; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

Review 9.  Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection.

Authors:  Saif Ahmad; Anjali Tejuja; Kimberley D Newman; Ryan Zarychanski; Andrew Je Seely
Journal:  Crit Care       Date:  2009-11-24       Impact factor: 9.097

10.  The vasopressin and copeptin response in patients with vasodilatory shock after cardiac surgery: a prospective, controlled study.

Authors:  Stefan Jochberger; Corinna Velik-Salchner; Viktoria D Mayr; Günter Luckner; Volker Wenzel; Gerda Falkensammer; Hanno Ulmer; Nils Morgenthaler; Walter Hasibeder; Martin W Dünser
Journal:  Intensive Care Med       Date:  2008-09-30       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.